GLAUKOS Corp
For the period ended Mar 31, 2025. Filed May 1, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 1, 2025
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 5. Other Information
Insider Trading Arrangements
On March 12, 2025, Gilbert H. Kliman, M.D., a member of the Company’s Board of Directors, adopted a new 10b5-1 trading plan (the “Trading Plan”). The Trading Plan is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Exchange Act. The Trading Plan provides for the potential sale of 10,000 shares of the Company’s common stock commencing June 16, 2025. The Trading Plan terminates on the earlier of November 7, 2025 or the date all shares are sold.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.